stalled for 11 weeks at 2.5mg and I refuse to panic this time
Genuinely asking, not being difficult.
Everyone in c/sideeffects repeats that non-peptide is important. I believe it, but I have never seen anyone show why, and when I search I get 23 threads of people agreeing with each other.
Is there a paper? Is there a measurement? Or is this one of those things that is true because it has been repeated since 2023?
I am not trying to be the "source?" guy. I would just like a source.
best — the order this archive was captured in
I love that this community will spend 40 comments on a detail. That pedantry is why the numbers here matter.
small molecule, not a peptide, purity discussion is different
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
Flair changed to match the content. Read the sidebar before posting next time and we are square.
Yeah, small molecule changes the whole game.
cite ATTAIN/ACHIEVE arms specifically
the non-peptide is whether this actually works long-term
small molecule purity is different testing than peptides
Inter-lab variance on this kind of assay is routinely 1–2 points.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
cite ATTAIN/ACHIEVE arms specifically
Yeah, small molecule changes the whole game.
availability speculation must be flaired Speculation
Yeah, small molecule changes the whole game.
- 1Inter-lab variance on this kind of assay is routinely 1–2 points. Different…10 comments in this branch · started by u/greta_nilsen